Q2 2020 Holdings
Filed 2020-08-12 | 10 holdings | $128.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Phreesia, Inc. | Common Stock | 71948P106 | $62.6K | 2,214,092 | 48.7% |
| Fate Therapeutics, Inc.(FATE) | Common Stock | 31189P102 | $39.1K | 1,139,783 | 30.4% |
| Lyra Therapeutics, Inc.(LYRA) | Common Stock | 55234L105 | $12.5K | 1,100,852 | 9.7% |
| Selecta Biosciences, Inc.(SELBUSD) | Common Stock | 816212104 | $7.9K | 2,773,479 | 6.1% |
| x4 Pharmaceuticals Inc.(ASNSUSD) | Common Stock | 98420X103 | $2.9K | 311,492 | 2.3% |
| Neuronetics, Inc.(STIM) | Common Stock | 64131A105 | $1.4K | 732,583 | 1.1% |
| Pulmatrix, Inc. | Common Stock | 74584P202 | $618 | 359,439 | 0.5% |
| Atyr Pharma Inc.(LIFEUSD) | Common Stock | 002120103 | $580 | 130,572 | 0.5% |
| Genocea Biosciences, Inc.(GNCAQ) | Common Stock | 372427401 | $566 | 246,078 | 0.4% |
| Dare Bioscience, Inc.(CERUEUR) | Common Stock | 23666P101 | $323 | 326,243 | 0.3% |